Jbf Capital, Inc. Bristol Myers Squibb CO Transaction History

Jbf Capital, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $2.77 Million - $3.14 Million	-47,919 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $500,215 - $554,304	8,710 Added 22.21%	47,919 $108,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $1.82 Million - $2.64 Million	39,209 New	39,209 $149,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $760,656 - $986,388	-15,600 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $252,650 - $314,900	5,000 Added 47.17%	15,600 $863,000
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $635,152 - $731,188	10,600 New	10,600 $670,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Jbf Capital, Inc. with notifications on news.